Skip to main content
Download PDF

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC Cancer volume 19, Article number: 366 (2019) Cite this article

The Original Article was published on 16 May 2017

Correction to: BMC Cancer

DOI 10.1186/s12885-017-3286-5

Following publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete. The complete figure legend is:

Fig. 1 Swimlane plot of time to response, treatment duration, and duration of follow-up for efficacy-evaluable patients who achieved response in the mBCC cohort (a), those in the laBCC cohort with treatment duration > 20 months (b), and those in the laBCC cohort who were treated for < 20 months (c). laBCC, locally advanced basal cell carcinoma; mBCC, metastatic basal cell carcinoma.

Reference

  1. Sekulic A, et al. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer. 2017;17:332. https://doi.org/10.1186/s12885-017-3286-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic Scottsdale, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA

    Aleksandar Sekulic

  2. Departments of Dermatology and Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA

    Michael R. Migden

  3. Service de Dermatologie, Hôpital Saint-Louis, 1 av claude Vellefaux, 75010, Paris, France

    Nicole Basset-Seguin

  4. Studienzentrum Dermatologische Onkologie, Universitätsklinikum Tübingen, Liebermeisterstr. 25, 72074, Tübingen, Germany

    Claus Garbe

  5. Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany

    Anja Gesierich

  6. University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA

    Christopher D. Lao

  7. Department of Dermatology, University of Pennsylvania Medical Center, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA

    Chris Miller

  8. Clinique de Dermatologie, Hôpital Claude Huriez, Inserm U1189, Lille, France

    Laurent Mortier

  9. Dermatology Department, St George Clinical School, University of New South Wales, Grey Street, Sydney, 2217, Australia

    Dedee F. Murrell

  10. The Angeles Clinic and Research Institute, 1818 Wilshire Boulevard, California, Los Angeles, USA

    Omid Hamid

  11. Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Jorge F. Quevedo

  12. Genentech, Inc., 1 DNA Way, South San Francisco, California, 94080, USA

    Jeannie Hou & Edward McKenna

  13. Roche Products Limited, Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, Al7 1TW, UK

    Natalie Dimier & Sarah Williams

  14. Klinikum für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Essen, Hufelandstrabe 55, 45147, Essen, Germany

    Dirk Schadendorf

  15. Universitätsklinikum Schleswig-Holstein, Schittenhelmstr, 7, D-24 105, Kiel, Germany

    Axel Hauschild

Authors
  1. Aleksandar Sekulic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael R. Migden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicole Basset-Seguin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anja Gesierich
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher D. Lao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chris Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Laurent Mortier
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dedee F. Murrell
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Omid Hamid
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jorge F. Quevedo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jeannie Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Edward McKenna
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Natalie Dimier
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Sarah Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Dirk Schadendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Axel Hauschild
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the ERIVANCE BCC Investigators

Corresponding author

Correspondence to Aleksandar Sekulic.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sekulic, A., Migden, M.R., Basset-Seguin, N. et al. Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer 19, 366 (2019). https://doi.org/10.1186/s12885-019-5568-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-019-5568-6

BMC Cancer

ISSN: 1471-2407

Contact us